Inpeco S.A. recalls FlexLab (FLX) System. Potassium Test System. in vitro diagnostic
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
- Products
-
- FlexLab (FLX) System. Potassium Test System. in vitro diagnostic
- Company
- Inpeco S.A.
- Where it was sold
-
US distribution to CA & NY.
States: California, New York
- Barcodes
07640172340004- Units affected
- 8 units
- About this recall
- FlexLab (FLX) System. Potassium Test System. in vitro diagnostic